Underrated efforts like Dangerous Animals and bona fide cinematic phenomenons like Sinners rank among the most thrilling and ...
Here are some of the TV highlights coming up from tomorrow, Saturday, January 3, including Corriedale and Celebrity SAS: Who ...
Inside the nationwide celebrations for the author's 250th birthday and the new generation of readers discovering her 19th ...
The International Space Station (ISS) is humanity's most expensive object and has been in orbit for 25 years. Read its ...
For decades, Showtime has produced some of the best stories we've seen on television. Let's dissect and rank the 15 greatest shows ever made at the network.
Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
Driven by a surging pipeline, the MASH therapeutic landscape is radically transforming as more drugs reach clinical trials. While Madrigal's Rezdiffra marked a groundbreaking first approval, it also ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...
Our obsession with serial killers and true crime probably has concerning implications for our collective psyche. Why are we so drawn to darkness? The same could be asked of many of the protagonists of ...
Over the past few years, interest in anime has grown exponentially, especially outside of Japan, which means streaming anime (legally) is now easier than ever. Regardless of wheth ...
Unjumble Michigan politics with MichMash. Each week, Cheyna Roth, Zach Gorchow and Alethia Kasben interview lawmakers and politicos, and unpack the statewide issues that affect you. MichMash is ...
If you're ready to add to your wishlist with some upcoming indie games, then you've come to the right place. Here, we've brought together some of the most exciting new indies coming our way in 2026 ...